Radiation exposure to the thymus during non-small cell lung cancer treatment is associated with worse outcomes in patients being treated for non-small cell lung cancer (NSCLC), according to a study published in the journal Annals of Oncology. Thymus Health and Radiation Risks in NSCLC Patients Until recently, the thymus was thought to be of little … Read more
Systemic cancer therapy timing significantly influences both treatment effectiveness and safety, according to a recent systematic review published in Critical Reviews in Oncology/Hematology (Ghidini A et al., August 2026). Aligning treatments with individual circadian rhythms, seasonal variations, and vitamin D levels could reshape how oncologists administer chemotherapy and immunotherapy. Circadian Rhythms and Molecular Biology in … Read more
Off-the-shelf CAR T-cell therapy being tested in clinical trials aims to expand treatment access for diffuse large B-cell lymphoma patients by using healthy donor cells instead of a patient’s own harvested white blood cells. According to blood cancer specialist Dr. John M. Burke of the Rocky Mountain Cancer Center, autologous treatments require complex logistics and … Read more
Lactylation-driven metabolic reprogramming acts as a central driver of therapeutic resistance in cancer, according to recent findings published in the journal Genes & Diseases by researchers Wanghao Zhang, Guanglong Huang, Woheng Tang, Jiaxian Li, Jingxian Chen, Yaojiang Feng, Kaichen Li, Can Pan, Shunshen Li, Huayang Zhang, Rongxu Ye, Hao Long, and Guo-zhong Yi. This cellular … Read more
According to medical experts, lifestyle interventions such as diet modifications, stress reduction, and natural remedies cannot cure cancer or replace evidence-based treatments like chemotherapy and surgery. While healthy habits support patient well-being, oncologists warn that delaying proven medical care to pursue alternative therapies allows the disease to progress and reduces survival chances. The Limits of … Read more
Researchers at Tel Aviv University have discovered that cancerous tumors can hijack immune cells, specifically macrophages, to accelerate their own growth. By using a new technology called Effero-seq, the team found that macrophages, which normally clear dead cells, are “reprogrammed” after consuming dead cancer cells to support tumor development and suppress anti-cancer immune activity. According … Read more
Cambodia’s King Norodom Sihamoni returned to Phnom Penh on Friday, July 3, following medical treatment for prostate cancer in Beijing. According to the Royal Palace and state media, the 73-year-old monarch’s health has improved after undergoing successful surgery overseen by Chinese medical specialists. Why did King Norodom Sihamoni seek treatment in China? The King traveled … Read more
Researchers from the Department of Breast Surgery at Fudan University Shanghai Cancer Center and the Department of Oncology at Shanghai Medical College, Fudan University have developed a new classification system for breast cancer based on the cancer-immunity cycle (CIC). Published in Cancer Biology & Medicine in 2026, this framework uses a “CIC score” to categorize … Read more
Researchers at Karolinska Institutet have successfully generated early germ cells from cryopreserved testicular tissue taken from prepubertal boys who underwent cancer treatment. Published in Human Reproduction Open, the study provides a proof-of-concept that somatic cells from damaged tissue can be reprogrammed into induced pluripotent stem cells (iPSCs) and subsequently directed to become primordial germ cells, … Read more
Researchers at the Rutgers Cancer Institute have successfully reduced patient wait times for complex cancer care by utilizing “digital twin” simulations to re-engineer clinic workflows. According to a study published in the Annals of Operations Research, this data-driven approach allowed the clinic to increase daily infusion capacity from 50 to 80 patients while slashing blood … Read more